Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era

被引：55
作者：
Agha, Mounzer E. [1 ]
Blake, Maggie [1 ]
Chilleo, Charles [3 ]
Wells, Alan [2 ]
Haidar, Ghady [4 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Med Ctr, Clin Labs, Pittsburgh, PA USA
[4] Univ Pittsburgh, Div Infect Dis, Sch Med, Pittsburgh, PA USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2021年 / 8卷 / 07期
基金：
美国国家卫生研究院;
关键词：
antibody; COVID; 19; vaccine; hematological malignancy; SARS; CoV; 2; COVID-19;
D O I：
10.1093/ofid/ofab353
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We measured severe acute respiratory syndrome coronavirus 2 immunoglobulin G responses in 67 patients with hematological malignancies after 2 messenger RNA vaccine doses. Forty-six percent were nonresponders; patients with B-cell chronic lymphocytic leukemia were at highest risk (77% nonresponders). Patients with hematological malignancies should continue wearing masks and socially distancing. Studies of revaccination, boosters, and humoral immune correlates of protection are needed.
引用
收藏
页数：5
相关论文
共 35 条
  • [11] Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients
    Cucchiari, David
    Egri, Natalia
    Bodro, Marta
    Herrera, Sabina
    Del Risco-Zevallos, Jimena
    Casals-Urquiza, Joaquim
    Cofan, Frederic
    Moreno, Asuncion
    Rovira, Jordi
    Banon-Maneus, Elisenda
    Ramirez-Bajo, Maria J.
    Ventura-Aguiar, Pedro
    Perez-Olmos, Anna
    Garcia-Pascual, Marta
    Pascal, Mariona
    Vilella, Anna
    Trilla, Antoni
    Rios, Jose
    Palou, Eduard
    Juan, Manel
    Bayes, Beatriu
    Diekmann, Fritz
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (08) : 2727 - 2739
  • [12] COVID-19 in Immunocompromised Hosts: What We Know So Far
    Fung, Monica
    Babik, Jennifer M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (02) : 340 - 350
  • [13] Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
    Haidar, Ghady
    Mellors, John W.
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (06) : E1397 - E1401
  • [14] Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
    Hensley, Matthew K.
    Bain, William G.
    Jacobs, Jana
    Nambulli, Sham
    Parikh, Urvi
    Cillo, Anthony
    Staines, Brittany
    Heaps, Amy
    Sobolewski, Michele D.
    Rennick, Linda J.
    Macatangay, Bernard J. C.
    Klamar-Blain, Cynthia
    Kitsios, Georgios D.
    Methe, Barbara
    Somasundaram, Ashwin
    Bruno, Tullia C.
    Cardello, Carly
    Shan, Feng
    Workman, Creg
    Ray, Prabir
    Ray, Anuradha
    Lee, Janet
    Sethi, Rahil
    Schwarzmann, William E.
    Ladinsky, Mark S.
    Bjorkman, Pamela J.
    Vignali, Dario A.
    Duprex, W. Paul
    Agha, Mounzer E.
    Mellors, John W.
    McCormick, Kevin D.
    Morris, Alison
    Haidar, Ghady
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : E815 - E821
  • [15] Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
    Herishanu, Yair
    Avivi, Irit
    Aharon, Anat
    Shefer, Gabi
    Levi, Shai
    Bronstein, Yotam
    Morales, Miguel
    Ziv, Tomer
    Arbel, Yamit Shorer
    Scarfo, Lydia
    Joffe, Erel
    Perry, Chava
    Ghia, Paolo
    [J]. BLOOD, 2021, 137 (23) : 3165 - 3173
  • [16] An mRNA Vaccine against SARS-CoV-2-Preliminary Report
    Jackson, L. A.
    Anderson, E. J.
    Rouphael, N. G.
    Roberts, P. C.
    Makhene, M.
    Coler, R. N.
    McCullough, M. P.
    Chappell, J. D.
    Denison, M. R.
    Stevens, L. J.
    Pruijssers, A. J.
    McDermott, A.
    Flach, B.
    Doria-Rose, N. A.
    Corbett, K. S.
    Morabito, K. M.
    O'Dell, S.
    Schmidt, S. D.
    Swanson, P. A.
    Padilla, M.
    Mascola, J. R.
    Neuzil, K. M.
    Bennett, H.
    Sun, W.
    Peters, E.
    Makowski, M.
    Albert, J.
    Cross, K.
    Buchanan, W.
    Pikaart-Tautges, R.
    Ledgerwood, J. E.
    Graham, B. S.
    Beigel, J. H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20) : 1920 - 1931
  • [17] SARS-CoV-2 evolution during treatment of chronic infection
    Kemp, Steven A.
    Collier, Dami A.
    Datir, Rawlings P.
    Ferreira, Isabella A. T. M.
    Gayed, Salma
    Jahun, Aminu
    Hosmillo, Myra
    Rees-Spear, Chloe
    Mlcochova, Petra
    Lumb, Ines Ushiro
    Roberts, David J.
    Chandra, Anita
    Temperton, Nigel
    Sharrocks, Katherine
    Blane, Elizabeth
    Modis, Yorgo
    Leigh, Kendra E.
    Briggs, John A. G.
    van Gils, Marit J.
    Smith, Kenneth G. C.
    Bradley, John R.
    Smith, Chris
    Doffinger, Rainer
    Ceron-Gutierrez, Lourdes
    Barcenas-Morales, Gabriela
    Pollock, David D.
    Goldstein, Richard A.
    Smielewska, Anna
    Skittrall, Jordan P.
    Gouliouris, Theodore
    Goodfellow, Ian G.
    Gkrania-Klotsas, Effrossyni
    Illingworth, Christopher J. R.
    McCoy, Laura E.
    Gupta, Ravindra K.
    [J]. NATURE, 2021, 592 (7853) : 277 - +
  • [18] Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
    Massarweh, Amir
    Eliakim-Raz, Noa
    Stemmer, Amos
    Levy-Barda, Adva
    Yust-Katz, Shlomit
    Zer, Alona
    Benouaich-Amiel, Alexandra
    Ben-Zvi, Haim
    Moskovits, Neta
    Brenner, Baruch
    Bishara, Jihad
    Yahav, Dafna
    Tadmor, Boaz
    Zaks, Tal
    Stemmer, Salomon M.
    [J]. JAMA ONCOLOGY, 2021, 7 (08) : 1133 - 1140
  • [19] Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
    Monin, Leticia
    Laing, Adam G.
    Munoz-Ruiz, Miguel
    McKenzie, Duncan R.
    Del Barrio, Irene Del Molino
    Alaguthurai, Thanussuyah
    Domingo-Vila, Clara
    Hayday, Thomas S.
    Graham, Carl
    Seow, Jeffrey
    Abdul-Jawad, Sultan
    Kamdar, Shraddha
    Harvey-Jones, Elizabeth
    Graham, Rosalind
    Cooper, Jack
    Khan, Muhammad
    Vidler, Jennifer
    Kakkassery, Helen
    Sinha, Shubhankar
    Davis, Richard
    Dupont, Liane
    Quijorna, Isaac Francos
    O'Brien-Gore, Charlotte
    Lee, Puay Ling
    Eum, Josephine
    Poole, Maria Conde
    Joseph, Magdalene
    Davies, Daniel
    Wu, Yin
    Swampillai, Angela
    North, Bernard, V
    Montes, Ana
    Harries, Mark
    Rigg, Anne
    Spicer, James
    Malim, Michael H.
    Fields, Paul
    Patten, Piers
    Di Rosa, Francesca
    Papa, Sophie
    Tree, Timothy
    Doores, Katie J.
    Hayday, Adrian C.
    Irshad, Sheeba
    [J]. LANCET ONCOLOGY, 2021, 22 (06) : 765 - 778
  • [20] Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
    Mulligan, Mark J.
    Lyke, Kirsten E.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Neuzil, Kathleen
    Raabe, Vanessa
    Bailey, Ruth
    Swanson, Kena A.
    Li, Ping
    Koury, Kenneth
    Kalina, Warren
    Cooper, David
    Fontes-Garfias, Camila
    Shi, Pei-Yong
    Tuereci, Oezlem
    Tompkins, Kristin R.
    Walsh, Edward E.
    Frenck, Robert
    Falsey, Ann R.
    Dormitzer, Philip R.
    Gruber, William C.
    Sahin, Ugur
    Jansen, Kathrin U.
    [J]. NATURE, 2020, 586 (7830) : 589 - +
1234